GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma Trading AD (XBUL:SFT) » Definitions » Cyclically Adjusted Revenue per Share

Sopharma Trading AD (XBUL:SFT) Cyclically Adjusted Revenue per Share : лв36.72 (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Sopharma Trading AD Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Sopharma Trading AD's adjusted revenue per share for the three months ended in Jun. 2024 was лв13.038. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is лв36.72 for the trailing ten years ended in Jun. 2024.

During the past 12 months, Sopharma Trading AD's average Cyclically Adjusted Revenue Growth Rate was 11.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-09-20), Sopharma Trading AD's current stock price is лв5.75. Sopharma Trading AD's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2024 was лв36.72. Sopharma Trading AD's Cyclically Adjusted PS Ratio of today is 0.16.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sopharma Trading AD was 0.20. The lowest was 0.15. And the median was 0.18.


Sopharma Trading AD Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Sopharma Trading AD's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma Trading AD Cyclically Adjusted Revenue per Share Chart

Sopharma Trading AD Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 31.25 34.33

Sopharma Trading AD Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.97 33.61 34.33 35.77 36.72

Competitive Comparison of Sopharma Trading AD's Cyclically Adjusted Revenue per Share

For the Medical Distribution subindustry, Sopharma Trading AD's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sopharma Trading AD's Cyclically Adjusted PS Ratio Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sopharma Trading AD's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Sopharma Trading AD's Cyclically Adjusted PS Ratio falls into.



Sopharma Trading AD Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sopharma Trading AD's adjusted Revenue per Share data for the three months ended in Jun. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=13.038/132.5538*132.5538
=13.038

Current CPI (Jun. 2024) = 132.5538.

Sopharma Trading AD Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 4.313 100.560 5.685
201409 4.308 100.428 5.686
201412 4.511 99.070 6.036
201503 4.652 99.621 6.190
201506 4.362 100.684 5.743
201509 4.635 100.392 6.120
201512 4.685 99.792 6.223
201603 4.653 100.470 6.139
201606 4.387 101.688 5.719
201612 0.000 101.863 0.000
201703 5.030 102.862 6.482
201706 4.899 103.349 6.283
201709 5.390 104.136 6.861
201712 6.604 104.011 8.416
201803 6.691 105.290 8.424
201806 6.390 106.317 7.967
201809 6.618 106.507 8.236
201812 7.282 105.998 9.106
201903 7.081 107.251 8.752
201906 6.843 108.070 8.393
201909 6.256 108.329 7.655
201912 7.470 108.420 9.133
202003 8.434 108.902 10.266
202006 7.011 108.767 8.544
202009 8.249 109.815 9.957
202012 10.039 109.897 12.109
202103 9.409 111.754 11.160
202106 9.319 114.631 10.776
202109 10.132 115.734 11.604
202112 10.111 117.630 11.394
202203 10.630 121.301 11.616
202206 10.318 125.017 10.940
202209 10.812 125.227 11.445
202212 11.376 125.222 12.042
202303 12.135 127.348 12.631
202306 11.862 128.729 12.214
202309 11.736 129.860 11.979
202312 13.088 129.419 13.405
202403 13.576 131.776 13.656
202406 13.038 132.554 13.038

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Sopharma Trading AD  (XBUL:SFT) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Sopharma Trading AD's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.75/36.72
=0.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Sopharma Trading AD was 0.20. The lowest was 0.15. And the median was 0.18.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Sopharma Trading AD Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Sopharma Trading AD's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma Trading AD Business Description

Industry
Traded in Other Exchanges
N/A
Address
Sunrise Street, Lachezar Stanchev, 5 Sopharma, Business Towers, Building A Floor 12, Sofia, BGR, 1756
Sopharma Trading AD is a Bulgaria based company operating in the pharmaceutical sector. The company is engaged in the distribution of pharmaceutical items, including a portfolio of international brands, medicinal products, medical supplies, sanitary and hygienic materials, vitamins, nutritional supplements, cosmetics, medical equipment, and equipment. It also provides turnkey solutions for the construction of medical and hospital establishments. In addition, the group also caters logistics solutions for import, storage, and distribution of goods to end customers.

Sopharma Trading AD Headlines

No Headlines